Variant report
Variant | esv3339630 |
---|---|
Chromosome Location | chr15:92199248-92200246 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs570674936 | chr15:92199254-92199255 | Weak transcription Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs538168101 | chr15:92199362-92199363 | Weak transcription Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs565712992 | chr15:92199429-92199430 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs74473416 | chr15:92199454-92199455 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs201411560 | chr15:92199559-92199560 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs180977356 | chr15:92199587-92199588 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs571655961 | chr15:92199638-92199639 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs533202021 | chr15:92199652-92199653 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs557288434 | chr15:92199697-92199698 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs574319417 | chr15:92199710-92199711 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs543322510 | chr15:92199752-92199753 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs150405660 | chr15:92199794-92199795 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs138117570 | chr15:92199830-92199831 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs185443137 | chr15:92199832-92199833 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs190020529 | chr15:92199851-92199852 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs181469624 | chr15:92199896-92199897 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs367832619 | chr15:92199918-92199919 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs544954590 | chr15:92199941-92199942 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs149124637 | chr15:92199957-92199958 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs535644028 | chr15:92199977-92199978 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs543567430 | chr15:92199997-92199998 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs78943265 | chr15:92200036-92200037 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs114773429 | chr15:92200119-92200120 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs370318436 | chr15:92200127-92200128 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs548859743 | chr15:92200132-92200133 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs373604730 | chr15:92200134-92200135 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs565649367 | chr15:92200170-92200171 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs35228350 | chr15:92200202-92200203 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs61651457 | chr15:92200204-92200205 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs186998131 | chr15:92200223-92200224 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs551508745 | chr15:92200225-92200226 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs571681367 | chr15:92200231-92200232 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs537135409 | chr15:92200238-92200239 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Schizophrenia | 19415332 | CNVD |
Breast cancer | 22522925 | CNVD |
Wilms tumour | 21544195 | CNVD |
cataract | 16735990 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Medulloblastoma | 21979893 | CNVD |
spastic paraplegia with thinning of corpus callosum | 19105190 | CNVD |
Schizophrenia | 21324950 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Disease | 21824424 | CNVD |
Melanoma | 18172304 | CNVD |
Gastric cancer | 17167181 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Multiple myeloma | 17550852 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Cancer | 16751803 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17133270 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Epilepsy | 19486360 | CNVD |
Acute myeloid leukemia | 17237825 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Developmental delay | 21147756 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Breast cancer | 21364760 | CNVD |
Schizophrenia | 17989066 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr15:92196400-92199600 | Weak transcription | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
2 | chr15:92198600-92200000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
3 | chr15:92198800-92199400 | Bivalent Enhancer | Primary Natural Killer cells fromperipheralblood | blood |
4 | chr15:92199000-92200200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
5 | chr15:92199000-92203200 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
6 | chr15:92199200-92199400 | Bivalent Enhancer | Primary T cells fromperipheralblood | blood |
7 | chr15:92199200-92199400 | Bivalent Enhancer | Primary T helper cells fromperipheralblood | blood |
8 | chr15:92199200-92203000 | Weak transcription | Dnd41 | blood |
9 | chr15:92199800-92200000 | Enhancers | Primary hematopoietic stem cells | blood |
10 | chr15:92199800-92200600 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
11 | chr15:92200000-92200400 | Enhancers | Brain Substantia Nigra | brain |
12 | chr15:92200000-92202200 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
13 | chr15:92200200-92200600 | Enhancers | Brain Hippocampus Middle | brain |